NCT03260504 2025-12-08Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney CancerUniversity of WashingtonPhase 1 Terminated6 enrolled 11 charts
NCT01472081 2021-12-02Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)Bristol-Myers SquibbPhase 1 Completed194 enrolled 18 charts